Utah Medical Products Inc
UTMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000706698
No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Utah Medical Products Inc changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 117 | 2 | 120 | +5 |
| Shares | 2.10M | 176.1K | 2.27M | +342.7K (+17.8%) |
| Value | $117.5M | $9.85M | $140.5M | +$32.8M (+30.5%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Utah Medical Products Inc at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 138,560 | $8.59M | 0.00% |
| Vanguard Fiduciary Trust Co | 19,056 | $1.18M | 0.00% |
| Vanguard Portfolio Management LLC | 17,437 | $1.08M | 0.00% |
| Raymond James Financial Inc | 5,201 | $322.4K | 0.00% |
| Colony Group, LLC | 4,898 | $303.6K | 0.00% |
| Sanctuary Advisors, LLC | 3,628 | $224.9K | 0.00% |
| Quadrature Capital Ltd | 3,321 | $205.9K | 0.00% |
| Empowered Funds, LLC | 3,278 | $203.2K | 0.00% |
| Advisory Services Network, LLC | 1,864 | $115.5K | 0.00% |
| Vanguard Global Advisers, LLC | 1,208 | $74.9K | 0.00% |
| Fifth Third Bancorp | 695 | $43.1K | 0.00% |
| JPL Wealth Management, LLC | 46 | $2.85K | 0.00% |
| BOK Financial Private Wealth, Inc. | 0 | $78 | 0.00% |
| Root Financial Partners, LLC | 1 | $62 | 0.00% |
Sold out (9)
Institutions that held Utah Medical Products Inc at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Citadel Advisors LLC | 10,954 | $613.0K |
| Isthmus Partners, LLC | 9,233 | $516.7K |
| Jane Street Group, LLC | 7,440 | $416.3K |
| Two Sigma Investments, LP | 5,153 | $288.4K |
| Two Sigma Advisers, LP | 4,900 | $274.2K |
| Meeder Asset Management Inc | 99 | $5.54K |
| Amalgamated Bank | 95 | $5.00K |
| Torren Management, LLC | 14 | $783 |
| Optima Capital LLC | 9 | $506 |
Not filed for Q1 2026 yet (2)
Institutions that held Utah Medical Products Inc at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 175,971 | $9.85M |
| Comerica Bank | 101 | $5.65K |